Healthcare supply chains: From cost control to strategic resilience
For more than a decade, healthcare supply chains were largely optimized around cost, efficiency and just-in-time inventory management. In 2026, a different reality is emerging. A combination of geopolitical instability, tariff uncertainty, product shortages, cybersecurity threats and evolving regulatory scrutiny is forcing health systems to rethink supply chain strategy as a core component of enterprise resilience rather than a back-office procurement function.
The growing cost of disruption
Recent data suggests the financial implications are becoming increasingly difficult to ignore. Hospital supply expenses now represent approximately 10.5% of the average hospital budget, while supply costs per calendar day have risen 9% year over year. In a recent survey of health system supply chain leaders, 60% cited rising costs as their top operational challenge, exceeding concerns related to disruption management, demand forecasting and vendor complexity.
The challenge extends beyond inflation. Health systems continue to confront persistent shortages of drugs, devices and critical supplies. Recent studies noted nearly 200 therapies have experienced shortages, with some lasting more than five years and select device shortages projected to continue into 2027. At the provider level, 67% of organizations reportedly spend at least 10 hours per week managing supply disruptions, while nearly 40% have delayed or canceled procedures due to product unavailability.
Federal policymakers are increasingly focused on supply chain resiliency as well. Earlier this year, the Centers for Medicare & Medicaid Services issued an Advance Notice of Proposed Rulemaking seeking public input on strengthening domestic supply chains for personal protective equipment and essential medicines. Among the concepts under review are incentives to encourage domestic sourcing and new approaches designed to reduce dependence on foreign manufacturers for critical medical products. CMS stated the initiative is intended to improve preparedness, strengthen domestic manufacturing and increase healthcare system resilience.
AI and analytics support resilient supply chains
At the same time, healthcare executives are leveraging data analytics and artificial intelligence to improve forecasting, supplier monitoring and procurement decisions. Industry forecasts suggest healthcare supply chains are moving beyond AI pilot programs toward measurable operational use cases focused on demand sensing, inventory optimization, contract compliance and supplier risk management. As health systems continue facing margin pressure, technology investments are increasingly evaluated based on their ability to reduce disruption-related costs and improve financial performance.
Resilience becomes a competitive advantage
Modern Healthcare, Becker’s Hospital Review and other industry observers have increasingly highlighted how supply chain leadership is evolving beyond purchasing and contracting into enterprise risk management, physician alignment and strategic planning. Supply chain performance is becoming a leading indicator of organizational resilience, with health systems placing greater emphasis on supplier diversification, domestic sourcing strategies, business continuity planning and analytics-driven decision making.
The most successful healthcare organizations will most likely be those that view supply chain resilience not as an operational expense, but as a strategic investment that protects margins, strengthens patient care continuity and improves long-term organizational stability.
Learn more about what’s happening in healthcare in our industry outlook.
